Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Blog
RealClear Radio Hour: Big Science with Jeremy Berg and Daniel Sarewitz
This week on RealClear Radio Hour, Drs. Jeremy Berg and Daniel Sarewitz discuss the politics and culture of Big Science.
Blog
Senate Democrats Block Zika Bill, for the Fourth Time
Three times in the past, Senate Democrats blocked a bill that would have provided funding to fight Zika, and suspended certain regulations (it would have…
Blog
Senate Democrats Block Anti-Zika Bill Yet Again
Democrats in the Senate have blocked a bill that would have provided federal funds to combat the spread of the Zika virus, reports The Hill.
Blog
New Drug Price Proposal Light on Competition, Heavy on Bureaucracy
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs.
Blog
Obamacare Shrinks Economy through Medicaid Expansion and Tax Credit Cliffs
Obamacare’s expansion of Medicaid reduced employment in those states that participated in it by a statistically significant extent, according to a recent study by Georgetown’s…
Blog
RealClear Radio Hour: American Indian, EpiPen, and Free Speech Fiascos
In this episode of RealClear Radio Hour, we discuss the fiascos of government overreach and overregulation—on American Indian reservations, in the EpiPen saga, and with…